The Dried Blood Spot Collection Cards Market was valued at USD 381.57 million in 2023 and is expected to reach USD 578.95 million by 2032, growing at a CAGR of 4.76% over 2024-2032. This report points to trends in prescription and use by region, fueled by increased demand for minimally invasive diagnostic testing and the expansion of newborn screening programs. The research investigates healthcare expenditures on DBS testing, breaking down government, commercial, private, and out-of-pocket payments and targeting increased access in rural and resource-constrained regions. Furthermore, technological innovations and advancements, such as improved sample stability and automation of DBS processing, are revolutionizing diagnostic processes and broadening clinical uses. The report also discusses regulatory and compliance trends as standardization initiatives and strict guidelines influence market uptake. R&D spending in DBS technology is gaining momentum, driving advancements in precision diagnostics and facilitating increased disease screening applications. Additionally, the use of DBS in non-clinical applications, including forensic toxicology and therapeutic drug monitoring, is also accelerating market growth.
The U.S. Dried Blood Spot Collection Cards Market grew at a CAGR of 3.8% over the forecast period of 2024-2032. In the United States, the DBS collection cards market is growing considerably due to augmented funding for neonatal screening programs, mounting demand for decentralized diagnostics, and growing research programs in precision medicine and distant sample collection.
Market Dynamics
Drivers
The increasing adoption of DBS in newborn screening, infectious disease diagnostics, and therapeutic drug monitoring.
With more than 140 million newborns born annually throughout the world, government-mandated newborn screening programs have been a major factor for DBS implementation. Moreover, the increased incidence of infectious diseases like HIV and hepatitis B & C, which are affecting millions of people worldwide, has promoted the use of DBS for the cost-effective and efficient detection of disease. Increased home-based and decentralized testing is also driving demand, as DBS provides a convenient and minimally invasive sample collection method. In addition, molecular diagnostic and automation advances have improved the accuracy and efficiency of DBS testing, making it a popular alternative to conventional venous blood collection. Pharmaceutical and contract research organization (CRO) industries are gaining increasing utility from DBS for pharmacokinetic and drug-monitoring studies due to the reductions in logistic difficulties posed by liquid blood samples. Additionally, forensic usage is increasing as a result of DBS's ability to store DNA and toxicology specimens for extended durations of time. The low cost, ease of storage, and lower biohazard risk of DBS also make it an appealing option for major diagnostic programs and public health efforts.
Restraints
The DBS Collection Cards Market faces several restraints, including limited sample volume capacity, which restricts its application in tests requiring larger blood samples.
The risk of contamination and degradation of the sample from improper handling, storage, or environmental conditions also threatens test accuracy. Most healthcare providers and diagnostic laboratories continue to use conventional venous blood draws because standardization of DBS processing and analysis is not followed consistently across laboratories or even by region. Additionally, approval and regulatory impediments curb large-scale adoption since DBS-based tests need to undergo thorough validation to conform to clinical diagnostic criteria. Another strong impediment is the lack of awareness and uptake of DBS in emerging economies, where traditional diagnosis stands out due to inadequate infrastructure and lack of trained professionals. Whereas DBS is economical for use in large-screening programs, the upfront expense of specialized instrumentation for analysis and processing can make it unpalatable to small labs. On top of this, delayed report turnaround times within some environments stemming from manual handling can restrict utilization in emergency cases. Absent further developments towards automation and regulation harmonization, the growth opportunities of the market could be restricted.
Opportunities
The DBS Collection Cards Market presents significant growth opportunities, particularly in the expanding field of personalized medicine and remote healthcare services.
Increased use of telemedicine and home-based diagnostics has provided new opportunities for DBS to enable patients to take samples without having to visit a healthcare setting. This is particularly useful in the management of chronic diseases like diabetes and cardiovascular monitoring, which involve regular blood tests. DBS use in forensic toxicology, drug analysis, and epidemiological studies is also increasing and offers opportunities to enter new markets. In addition, the combination of DBS with next-generation sequencing (NGS) and sophisticated molecular diagnostics is opening up new uses in genetic testing and oncology screening. Developing economies present untapped promise, as low- and middle-income country governments increasingly embrace low-cost diagnostic technologies to fight infectious diseases. In addition, advances in automated DBS analysis and digital health integration can increase efficiency and broaden usage. Partnerships between research organizations and biotech companies for the creation of enhanced DBS-based diagnostic products are likely to fuel future growth. Through these opportunities, market participants can diversify their product offerings and penetrate new clinical and non-clinical markets, thereby improving the growth path of the market.
Challenges
The widespread adoption of DBS collection cards faces multiple challenges, including sample integrity issues, regulatory inconsistencies, and limited compatibility with certain laboratory techniques.
Variations in blood absorption, environmental factors, and mis-handling may influence test validity. Moreover, the absence of global regulatory harmonization complicates compliance for laboratories. DBS also faces issues with high-throughput scalability and specialized testing needs, e.g., plasma separation. Lack of confidence from healthcare professionals and forensic implications due to sample tampering are other inhibitors of market growth. A need to overcome these challenges using technological innovations, standardization, and awareness programs is imperative for DBS to extend its clinical and research adoption.
By Application Type
The Newborn Screening (NBS) segment led the DBS Collection Cards Market in 2023, with a share of 23.19% of the total revenue. This is largely due to the extensive use of DBS in neonatal genetic and metabolic screening programs. Mandatory newborn screening programs by governments and the growing number of inherited disorders have also stimulated demand for DBS collection cards in this segment.
The Forensic application segment is anticipated to be the fastest-growing segment throughout the forecast period. The growing use of DBS for forensic toxicology, drug screening, and DNA typing, as well as its benefit in preserving samples for the long term and easy storage, is fueling its growth. Forensic research investment growth and applications in crime investigations are anticipated to boost the demand for DBS cards in this segment.
By Card Type
The Whatman 903 segment held a 38.5% market share in 2023, due to the card's high reliability in clinical diagnostics and wide regulatory acceptance in newborn screening programs all over the world. The card's sample preservation quality and compatibility with numerous analytical methods have also made it the industry's preferred option.
The FTA cards market is anticipated to witness considerable growth over the forecast period. The growing demand for DNA analysis and molecular diagnostics, especially in forensic and research uses, is fueling the use of FTA cards. Their capacity to stabilize nucleic acids for prolonged periods without the need for refrigeration makes them a useful asset for forensic and research laboratories.
By End Use
The Hospitals & Clinics segment maintained the largest market share in 2023 at 68.9%. The market's control by this segment is explained by the large volume of DBS testing done in hospitals for newborn screening, infection testing, and monitoring chronic diseases. Hospitals are also primary centers for government-sponsored newborn screening programs, thus further increasing the segment's market share.
The Diagnostics Centers segment is likely to be the highest-growing segment in the years to come. The growing demand for decentralized and home-based diagnostics and the rising use of DBS testing for infectious disease testing and monitoring therapeutic drugs are driving growth within this segment. Increased diagnostic facilities in emerging nations and the inclination toward cost-reducing test solutions are set to drive continued market growth.
Regional Analysis
The North American region led the Dried Blood Spot (DBS) Collection Cards Market in 2023 due to well-established programs for newborn screening, high penetration of sophisticated diagnostic technologies, and huge investment in forensic and pharmaceutical research. The United States dominated the market, with robust government efforts like the Newborn Screening Saves Lives Act backing up DBS use in neonatal testing. Furthermore, the increasing emphasis of the region on decentralized testing and home-based sample collection has also driven the market forward. Europe is no exception, with nations such as Germany, France, and the UK experiencing extensive adoption of clinical diagnostics and forensic purposes. Strict regulatory policies facilitating DBS-based screening for infectious diseases and genetic disorders drive the European market.
The Asia-Pacific region is predicted to be the highest-growing market, driven by increased healthcare awareness, growing newborn screening programs, and rising investment in diagnostic facilities. China, India, and Japan are also seeing fast-growing adoption because of government efforts toward better neonatal healthcare. Growing infections like hepatitis and HIV across the region are also fueling demand for inexpensive DBS-based testing. Also, increasing research partnerships and improvements in molecular diagnostics are making the Asia-Pacific region a major growth center, with the greatest forecasted market growth in the coming years.
QIAGEN – QIAsymphony DBS, QIAcard FTA, QIAcard Dry Blood Spot
PerkinElmer – 226 Sample Collection Device, NeoBase DBS Kit, PerkinElmer 226 DBS Card
Roche – Cobas DBS System, Roche DBS Sample Collection Cards
Shimadzu Corporation – Capitainer B, DBS-MS 500
Ahlstrom-Munksjö – Ahlstrom 226, GenSaver, GenCollect
Pall Corporation – Pall Vivid DBS Cards, Pall 226 DBS Cards
Eastern Business Forms, Inc. – 903 Protein Saver Cards, 226 Sample Collection Cards
Archimed Life Science GmbH – DBS Micro-Card, DBS Protein Card
Centogene N.V. – CentoCard Dried Blood Spot Collection Cards
GE Healthcare – Whatman 903 Protein Saver Cards, FTA Elute Cards
Recent Developments
In Oct 2024, Massachusetts-based Revvity introduced Revvity Transcribe AI, an AI-driven tool that digitizes handwritten lab test requests using optical character recognition (OCR) technology. This innovation aims to streamline data entry in clinical laboratories, enhancing efficiency and reducing manual workload.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 381.57 million |
| Market Size by 2032 | USD 578.95 million |
| CAGR | CAGR of 4.76% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Application Type [Newborn Screening (NBS), Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, CRO/Research, Other Applications] • By Card Type [Whatman 903, Ahlstrom 226, FTA, Others] • By End Use [Hospitals & Clinics, Diagnostics Centers, Others] |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | QIAGEN, PerkinElmer, Roche, Shimadzu Corporation, Ahlstrom-Munksjö, Pall Corporation, Eastern Business Forms, Inc., Archimed Life Science GmbH, Centogene N.V., GE Healthcare. |
Ans: The market is expected to grow at a compound annual growth rate (CAGR) of 4.76% during the forecast period.
Ans: The Dried Blood Spot Collection Cards market is predicted to reach a valuation of USD 578.95 million by 2032, increasing from USD 578.95 million in 2023.
Ans: The increasing adoption of DBS in newborn screening, infectious disease diagnostics, and therapeutic drug monitoring.
Ans: The DBS Collection Cards Market faces several restraints, including limited sample volume capacity, which restricts its application in tests requiring larger blood samples.
Ans: North America dominates the Dried Blood Spot Collection Cards market.
Table of contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research & Academic Institutes Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research & Academic Institutes Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Prescription and Usage Trends (2023), by Region
5.2 Healthcare Spending on DBS Testing, by Region (Government, Commercial, Private, Out-of-Pocket) (2023)
5.3 Technological Advancements and Innovations
5.4 Regulatory and Compliance Trends
5.5 Research and Development Investments in DBS Technology
5.6 Adoption of DBS in Non-Medical Applications
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and Promotional Activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Dried Blood Spot Collection Cards Market Segmentation, by Application Type
7.1 Chapter Overview
7.2 Newborn Screening (NBS)
7.2.1 Newborn Screening (NBS) Market Trends Analysis (2020-2032)
7.2.2 Newborn Screening (NBS) Market Size Estimates and Forecasts to 2032 (USD Million)
7.3 Infectious Diseases Testing
7.3.1 Infectious Diseases Testing Market Trends Analysis (2020-2032)
7.3.2 Infectious Diseases Testing Market Size Estimates and Forecasts to 2032 (USD Million)
7.4 Therapeutic Drug Monitoring
7.4.1 Therapeutic Drug Monitoring Market Trends Analysis (2020-2032)
7.4.2 Therapeutic Drug Monitoring Market Size Estimates and Forecasts to 2032 (USD Million)
7.5 Forensics
7.5.1 Forensics Market Trends Analysis (2020-2032)
7.5.2 Forensics Market Size Estimates and Forecasts to 2032 (USD Million)
7.6 CRO/Research
7.6.1 CRO/Research Market Trends Analysis (2020-2032)
7.6.2 CRO/Research Market Size Estimates and Forecasts to 2032 (USD Million)
7.7 Other Applications
7.7.1 Other Applications Market Trends Analysis (2020-2032)
7.7.2 Other Applications Market Size Estimates and Forecasts to 2032 (USD Million)
8. Dried Blood Spot Collection Cards Market Segmentation, by Card Type
8.1 Chapter Overview
8.2 Whatman 903
8.2.1 Whatman 903 Market Trends Analysis (2020-2032)
8.2.2 Whatman 903 Market Size Estimates and Forecasts to 2032 (USD Million)
8.3 Ahlstrom 226
8.3.1 Ahlstrom 226 Market Trends Analysis (2020-2032)
8.3.2 Ahlstrom 226 Market Size Estimates and Forecasts to 2032 (USD Million)
8.4 FTA
8.4.1 FTA Market Trends Analysis (2020-2032)
8.4.2 FTA Market Size Estimates and Forecasts to 2032 (USD Million)
8.5 Others
8.5.1 Others Market Trends Analysis (2020-2032)
8.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Million)
9. Dried Blood Spot Collection Cards Market Segmentation, by End Use
9.1 Chapter Overview
9.2 Hospitals & Clinics
9.2.1 Hospitals & Clinics Market Trends Analysis (2020-2032)
9.2.2 Hospitals & Clinics Market Size Estimates and Forecasts to 2032 (USD Million)
9.3 Diagnostics Centers
9.3.1 Diagnostics Centers Market Trends Analysis (2020-2032)
9.3.2 Diagnostics Centers Market Size Estimates and Forecasts to 2032 (USD Million)
9.4 Others
9.4.1 Others Market Trends Analysis (2020-2032)
9.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Million)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.2.3 North America Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.2.4 North America Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.2.5 North America Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.2.6 USA
10.2.6.1 USA Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.2.6.2 USA Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.2.6.3 USA Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.2.7 Canada
10.2.7.1 Canada Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.2.7.2 Canada Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.2.7.3 Canada Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.2.8 Mexico
10.2.8.1 Mexico Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.2.8.2 Mexico Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.2.8.3 Mexico Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.3.1.3 Eastern Europe Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.3.1.4 Eastern Europe Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.3.1.5 Eastern Europe Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.1.6 Poland
10.3.1.6.1 Poland Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.3.1.6.2 Poland Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.3.1.6.3 Poland Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.1.7 Romania
10.3.1.7.1 Romania Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.3.1.7.2 Romania Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.3.1.7.3 Romania Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.3.1.8.2 Hungary Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.3.1.8.3 Hungary Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.1.9 turkey
10.3.1.9.1 Turkey Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.3.1.9.2 Turkey Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.3.1.9.3 Turkey Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.3.1.10.2 Rest of Eastern Europe Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.3.1.10.3 Rest of Eastern Europe Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.3.2.3 Western Europe Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.3.2.4 Western Europe Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.3.2.5 Western Europe Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.2.6 Germany
10.3.2.6.1 Germany Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.3.2.6.2 Germany Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.3.2.6.3 Germany Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.2.7 France
10.3.2.7.1 France Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.3.2.7.2 France Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.3.2.7.3 France Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.2.8 UK
10.3.2.8.1 UK Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.3.2.8.2 UK Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.3.2.8.3 UK Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.2.9 Italy
10.3.2.9.1 Italy Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.3.2.9.2 Italy Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.3.2.9.3 Italy Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.2.10 Spain
10.3.2.10.1 Spain Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.3.2.10.2 Spain Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.3.2.10.3 Spain Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.3.2.11.2 Netherlands Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.3.2.11.3 Netherlands Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.3.2.12.2 Switzerland Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.3.2.12.3 Switzerland Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.2.13 Austria
10.3.2.13.1 Austria Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.3.2.13.2 Austria Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.3.2.13.3 Austria Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.3.2.14.2 Rest of Western Europe Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.3.2.14.3 Rest of Western Europe Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.4.3 Asia Pacific Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.4.4 Asia Pacific Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.4.5 Asia Pacific Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.4.6 China
10.4.6.1 China Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.4.6.2 China Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.4.6.3 China Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.4.7 India
10.4.7.1 India Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.4.7.2 India Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.4.7.3 India Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.4.8 Japan
10.4.8.1 Japan Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.4.8.2 Japan Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.4.8.3 Japan Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.4.9 South Korea
10.4.9.1 South Korea Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.4.9.2 South Korea Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.4.9.3 South Korea Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.4.10 Vietnam
10.4.10.1 Vietnam Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.4.10.2 Vietnam Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.4.10.3 Vietnam Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.4.11 Singapore
10.4.11.1 Singapore Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.4.11.2 Singapore Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.4.11.3 Singapore Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.4.12 Australia
10.4.12.1 Australia Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.4.12.2 Australia Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.4.12.3 Australia Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.4.13.2 Rest of Asia Pacific Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.4.13.3 Rest of Asia Pacific Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.5.1.3 Middle East Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.5.1.4 Middle East Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.5.1.5 Middle East Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.5.1.6 UAE
10.5.1.6.1 UAE Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.5.1.6.2 UAE Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.5.1.6.3 UAE Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.5.1.7.2 Egypt Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.5.1.7.3 Egypt Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.5.1.8.2 Saudi Arabia Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.5.1.8.3 Saudi Arabia Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.5.1.9.2 Qatar Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.5.1.9.3 Qatar Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.5.1.10.2 Rest of Middle East Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.5.1.10.3 Rest of Middle East Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.5.2.3 Africa Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.5.2.4 Africa Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.5.2.5 Africa Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.5.2.6.2 South Africa Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.5.2.6.3 South Africa Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.5.2.7.2 Nigeria Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.5.2.7.3 Nigeria Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.5.2.8.2 Rest of Africa Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.5.2.8.3 Rest of Africa Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.6.3 Latin America Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.6.4 Latin America Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.6.5 Latin America Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.6.6 Brazil
10.6.6.1 Brazil Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.6.6.2 Brazil Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.6.6.3 Brazil Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.6.7 Argentina
10.6.7.1 Argentina Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.6.7.2 Argentina Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.6.7.3 Argentina Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.6.8 Colombia
10.6.8.1 Colombia Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.6.8.2 Colombia Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.6.8.3 Colombia Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Application Type (2020-2032) (USD Million)
10.6.9.2 Rest of Latin America Dried Blood Spot Collection Cards Market Estimates and Forecasts, by Card Type (2020-2032) (USD Million)
10.6.9.3 Rest of Latin America Dried Blood Spot Collection Cards Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
11. Company Profiles
11.1 QIAGEN
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Product / Services Offered
11.1.4 SWOT Analysis
11.2 PerkinElmer
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Product / Services Offered
11.2.4 SWOT Analysis
11.3 Roche
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Product / Services Offered
11.3.4 SWOT Analysis
11.4 Shimadzu Corporation
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Product / Services Offered
11.4.4 SWOT Analysis
11.5 Ahlstrom-Munksjö
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Product / Services Offered
11.5.4 SWOT Analysis
11.6 Pall Corporation
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Product / Services Offered
11.6.4 SWOT Analysis
11.7 Eastern Business Forms, Inc.
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Product / Services Offered
11.7.4 SWOT Analysis
11.8 Archimed Life Science GmbH
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Product / Services Offered
11.8.4 SWOT Analysis
11.9 Centogene N.V.
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Product / Services Offered
11.9.4 SWOT Analysis
11.10 GE Healthcare
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Product / Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Application Type
Newborn Screening (NBS)
Infectious Diseases Testing
Therapeutic Drug Monitoring
Forensics
CRO/Research
Other Applications
By Card Type
Whatman 903
Ahlstrom 226
FTA
Others
By End Use
Hospitals & Clinics
Diagnostics Centers
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Drug Screening Market was valued at USD 7.6 billion in 2023 and is expected to reach USD 29.7 billion by 2032 and grow at a CAGR of 16.3% by 2024-2032.
The Personalized Nutrition Market Size was valued at USD 12.06 Billion in 2023, and is expected to reach USD 41.10 Billion by 2032, and grow at a CAGR of 15.04% over the forecast period 2024-2032.
The Benign Prostatic Hyperplasia (BPH) Treatment Market Size was valued at USD 1.57 billion in 2023 and is expected to reach USD 3.38 billion by 2032 and grow at a CAGR of 8.92% over the forecast period 2024-2032.
The Hematology Diagnostics Market Size was valued at USD 3.85 billion in 2023 and is expected to reach USD 6.86 billion by 2032 and grow at a CAGR of 6.64% over the forecast period 2024-2032.
The Dental Consumables Market Size was valued at USD 34.55 billion in 2023 and is expected to reach USD 70.55 billion by 2032 and grow at a CAGR of 8.27% over the forecast period 2024-2032.
The Allergic Conjunctivitis Market size was valued at USD 3.03 billion in 2023 and is expected to reach USD 4.90 billion by 2032 with an emerging CAGR of 5.7% Over the Forecast Period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
